Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Which is Outstanding, Local Ozone Injection or Dextrose Prolotherapy Injection in Chronic Plantar Fasciitis?: a Randomised Controlled Study"

NCT05984121 is registered in ClinicalTrials.gov with Ahi Evran University Education and Research Hospital as lead sponsor.

NCT NCT05984121
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05984121 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Which is Outstanding, Local Ozone Injection or Dextrose Prolotherapy Injection in Chronic Plantar Fasciitis?: a Randomised Controlled Study"
Lead sponsor
Ahi Evran University Education and Research Hospital
Phase
Not applicable
Overall status
Completed
Start date
August 5, 2023
Completion date
March 15, 2024
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

plantar fascitis